awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38865905-7A37925D-5A94-4390-8B09-A605C8D2E574
Q38865905-7A37925D-5A94-4390-8B09-A605C8D2E574
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38865905-7A37925D-5A94-4390-8B09-A605C8D2E574
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
P2860
Q38865905-7A37925D-5A94-4390-8B09-A605C8D2E574
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38865905-7A37925D-5A94-4390-8B09-A605C8D2E574
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef410dca34d64bd08d2320d339833c694e593fc5
P2860
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy